- Scrip Originals
- Featured Topics
Brought to you by
Kyn emerges from stealth mode with $49mm Series A round
03 Apr 2018
Immuno-oncology start-up Kyn Therapeutics has emerged from stealth mode and raised $49mm in Series A funding from Atlas Venture and OrbiMed.
- Venture Financing
Already a Biomedtracker subscriber? You have access to the full deal record through your subscription
Want to become a subscriber? Subscribers get more deal details, updates, deal financials and deal products.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com